A pair of San Antonio biotech companies, BioBridge Global and StemBioSys Inc., have agreed to expand the scope of their collaborative relationship in an effort to bring a new source of stem cells to the research market.
Recent Posts
- Robin Roberts Praises ‘Superhero’ Stem Cell Donors on 12-Year Anniversary of GMA Return
- Cellular ‘scaffold’ enables myoblast implants on healthy muscle to advance regenerative medicine
- Daily briefing: CAR-T-cell therapy recipient nears two decades in cancer remission
- Bone Marrow Banking Boosts Life-Saving Cell Therapy Development
- Experts explore the future of iPSC-based cell therapies
- Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells